These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Long-term 3,5,3'-triiodothyroacetic acid therapy in a child with hyperthyroidism caused by thyroid hormone resistance: pharmacological study and therapeutic recommendations. Anzai R; Adachi M; Sho N; Muroya K; Asakura Y; Onigata K Thyroid; 2012 Oct; 22(10):1069-75. PubMed ID: 22947347 [TBL] [Abstract][Full Text] [Related]
5. Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance. Radetti G; Persani L; Molinaro G; Mannavola D; Cortelazzi D; Chatterjee VK; Beck-Peccoz P Thyroid; 1997 Oct; 7(5):775-8. PubMed ID: 9349583 [TBL] [Abstract][Full Text] [Related]
6. 9 years follow-up of a patient with pituitary form of resistance to thyroid hormones (PRTH): comparison of two treatment periods of D-thyroxine and triiodothyroacetic acid (TRIAC). Guran T; Turan S; Bircan R; Bereket A J Pediatr Endocrinol Metab; 2009 Oct; 22(10):971-8. PubMed ID: 20020587 [TBL] [Abstract][Full Text] [Related]
7. TRIAC (3,5,3'-triiodothyroacetic acid) has parallel effects at the pituitary and peripheral tissue levels in thyroid cancer patients treated with L-thyroxine. Mechelany C; Schlumberger M; Challeton C; Comoy E; Parmentier C Clin Endocrinol (Oxf); 1991 Aug; 35(2):123-8. PubMed ID: 1934526 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of pituitary and peripheral tissue markers of thyroid hormone action in an Iranian family with resistance to thyroid hormone. Ghazi AA; Refetoff S Thyroid; 1996 Dec; 6(6):589-93. PubMed ID: 9001193 [TBL] [Abstract][Full Text] [Related]
9. Endocrine and neuropsychological assessment in a child with a novel mutation of thyroid hormone receptor: response to 12-month triiodothyroacetic acid (TRIAC) therapy. Torre P; Bertoli M; Di Giovanni S; Scommegna S; Conte C; Novelli G; Cianfarani S J Endocrinol Invest; 2005; 28(7):657-62. PubMed ID: 16218051 [TBL] [Abstract][Full Text] [Related]
10. Differentiated thyroid carcinoma in a girl with resistance to thyroid hormone management with triiodothyroacetic acid. Ramos-Prol A; Antonia Pérez-Lázaro M; Isabel del Olmo-García M; León-de Zayas B; Moreno-Macián F; Navas-de Solis S; Merino-Torres JF J Pediatr Endocrinol Metab; 2013; 26(1-2):133-6. PubMed ID: 23457315 [TBL] [Abstract][Full Text] [Related]
11. [Resistance to thyroid hormone]. Yamada M Nihon Rinsho; 2006 Dec; 64(12):2237-42. PubMed ID: 17154085 [TBL] [Abstract][Full Text] [Related]
12. 3,5,3'-Triiodothyroacetic acid minimizes the pituitary thyrotrophin secretion in patients on levo-thyroxine therapy after ablative therapy for differentiated thyroid carcinoma. Mueller-Gaertner HW; Schneider C Clin Endocrinol (Oxf); 1988 Apr; 28(4):345-51. PubMed ID: 3142712 [TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus in a girl with thyroid hormone resistance syndrome: a little recognized interaction between the two diseases. Stagi S; Manoni C; Cirello V; Covelli D; Giglio S; Chiarelli F; Seminara S; de Martino M Hormones (Athens); 2014; 13(4):561-7. PubMed ID: 25402385 [TBL] [Abstract][Full Text] [Related]
14. [Triiodothyroacetic acid in euthyroid goiter. New data on its mechanisms of action. Comparison with L-thyroxin]. Pisarev MA; Brenta G; Schnitman M; Kleiman de Pisarev DL Bull Acad Natl Med; 2007 Nov; 191(8):1705-15; discussion 1715. PubMed ID: 18666468 [TBL] [Abstract][Full Text] [Related]
16. Hyperthyroidism due to familial pituitary resistance to thyroid hormone: successful control with 3, 5, 3' triiodothyroacetic associated to propranolol. Aguilar Diosdado M; Escobar-Jimenez L; Fernandez Soto ML; Garcia Curiel A; Escobar-Jimenez F J Endocrinol Invest; 1991 Sep; 14(8):663-8. PubMed ID: 1774450 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic applications of thyroid hormone analogues in resistance to thyroid hormone (RTH) syndromes. Groeneweg S; Peeters RP; Visser TJ; Visser WE Mol Cell Endocrinol; 2017 Dec; 458():82-90. PubMed ID: 28235578 [TBL] [Abstract][Full Text] [Related]
18. 3,5,3'-triiodothyroacetic acid therapy for thyroid hormone resistance. Kunitake JM; Hartman N; Henson LC; Lieberman J; Williams DE; Wong M; Hershman JM J Clin Endocrinol Metab; 1989 Aug; 69(2):461-6. PubMed ID: 2753985 [TBL] [Abstract][Full Text] [Related]
19. Selective pituitary resistance to thyroid hormone after treatment of a toxic multinodular goiter. Vesely DL South Med J; 1988 Sep; 81(9):1173-6. PubMed ID: 3420449 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of 3,5,3'-triiodothyroacetic Acid and triiodothyronine on goiter prevention and involution and on hepatic and skeletal parameters in rats. Alvarez L; Burgueño A; Zeni S; Randi AS; Hernández S; Hockl P; Pisarev MA; Kleiman de Pisarev DL Horm Metab Res; 2004 May; 36(5):291-7. PubMed ID: 15156408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]